Private company
RXi Pharmaceuticals
Biotechnology company in U.S.
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.2 It is headquartered in Marlborough.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
2011Founded1
- Industrybiotechnology1
- HeadquartersMarlborough1
- Websitewww.rxipharma.com
- Legal formpublic company1
See how the biggest companies compare on our leaderboards
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.2
Timeline
- 2011Founded Founded1
Links
- Websitewww.rxipharma.com1
- WikipediaPhio Pharmaceuticals
- WikidataQ25245130
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataRXi Pharmaceuticals on Wikidata
- 2WikipediaRXi Pharmaceuticals on Wikipedia